Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DLGAP4 antisense RNA 1 (DLGAP4-AS1) is a long non-coding RNA (lncRNA) located on chromosome 20, also known by the alias CCAT7[2][4][5][6]. Unlike protein-coding genes or classical therapeutic targets such as receptors or enzymes, DLGAP4-AS1 does not produce a protein product and is classified as an RNA gene—specifically in the lncRNA family[5]. Long non-coding RNAs like DLGAP4-AS1 are typically involved in the regulation of gene expression at the transcriptional and post-transcriptional level. Diseases associated with DLGAP4-AS1 include various cancers, with particular mention of colorectal cancer, as well as rare developmental disorders such as megacystis-microcolon-intestinal hypoperistalsis syndrome 4[5]. There are currently no known drugs reported to target DLGAP4-AS1 directly, nor is it established as a direct therapeutic target or clinical biomarker. Its function, nomenclature, and disease associations are distinct from the protein-coding gene DLGAP4, which is a synaptic scaffold protein with broader neurological roles[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DLGAP4 antisense RNA 1 (DLGAP4-AS1).